|
CardioMetabolic Bridge Aims to Move More Research from Lab to Treatment
|
Written by: J. Smith |
Hits: 63
|
|
Novo Nordisk Reports IT Security Incident Involving Some Clinical Trial Data
|
Written by: J. Smith |
Hits: 88
|
|
FDA Clears Dexcom Stelo as First Over-the-Counter CGM for Children
|
Written by: J. Smith |
Hits: 92
|
|
CONNECT Trial Strengthens the Case for CGM in Non-Insulin Type 2 Diabetes
|
Written by: J. Smith |
Hits: 92
|
|
Dexcom G8 Promises Smaller Size and Adaptive Accuracy
|
Written by: J. Smith |
Hits: 160
|
|
New ACHIEVE-4 Data May Help Address FDA Safety Questions on Lilly’s Foundayo
|
Written by: J. Smith |
Hits: 176
|
|
Novo Nordisk Expands AI Strategy Through New OpenAI Partnership
|
Written by: J. Smith |
Hits: 206
|
|
Lilly’s Foundayo Approval Brings a More Flexible GLP-1 Pill to Weight Loss Care
|
Written by: J. Smith |
Hits: 171
|
|
Novo Nordisk Reports Promising Phase 2 Data for UBT251 in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 174
|
|
Novo Nordisk Expands DTC Push With New Wegovy Subscription Program
|
Written by: J. Smith |
Hits: 177
|
